Abacavir and Lamivudine
- Generic Name
- Abacavir and Lamivudine
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
本品可与其它抗逆转录病毒药联合用药，适用于治疗HIV-1感染。
- Associated Conditions
- -
- Associated Therapies
- -
Dual Therapy With Boosted Darunavir + Dolutegravir
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Technical University of Munich
- Target Recruit Count
- 269
- Registration Number
- NCT02486133
- Locations
- 🇩🇪
Klinikum rechts der Isar, Munich, Germany
Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients
- First Posted Date
- 2006-04-26
- Last Posted Date
- 2008-01-29
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT00318123
- Locations
- 🇪🇸
Hospital Central de Asturias, Asturias, Oviedo, Spain
🇪🇸Hopsital Gregorio Marañón, Madrid, Spain
🇪🇸Hospital Virgen Macarena, Sevilla, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath